In a fluorescent-lit laboratory at the University of Cambridge, a tiny embryo just seven days old held a secret that scientists have long suspected but never proven. When researchers blocked a single gene called NANOG, the cells that would form the human body simply failed to appear—while the cells destined to become the placenta and yolk sac continued developing normally. It was a moment of quiet precision that revealed something profound about the earliest chapters of human life. The research, published in Nature and led by Professor Kathy Niakan at the Loke Centre for Trophoblast Research, marks the first time that base editing—a next-generation form of genome editing—has been used not to treat disease, but to understand how we develop in the first place. The technique works by changing a single nucleotide base pair within the roughly 3 billion base pairs that make up the human genome. Think of it like finding and editing one specific letter in an encyclopedia written in triplicate, stored inside every cell of your body. "Base editing represents a significant advance on conventional CRISPR/Cas9 because it carries a far lower risk of causing unintended chromosome errors," said Professor Niakan. "That's an incredible feat." The team demonstrated that NANOG is critical for the development of pluripotent cells—the remarkable master cells that can become any tissue in the body. At the blastocyst stage, just days after fertilization, roughly 90% of an embryo's cells are already earmarked to become the placenta, while only 10% will form the epiblast, the tissue that gives rise to the body itself. These pluripotent cells, which arise in the part of the embryo with high NANOG activity, are already used extensively in biomedical research for drug testing and disease modeling. Now, by revealing NANOG's essential role, scientists have opened a new window into early human development. The implications stretch well beyond basic science. Understanding genes that drive early development could eventually improve IVF success rates and help explain why some pregnancies end in miscarriage. In the future, base editing might also be used to prevent devastating inherited conditions such as cystic fibrosis and Huntington's disease, though extensive safety testing, legal frameworks, and broad public debate would be required before any clinical applications in the UK. For now, the research stands as proof that scientific curiosity, wielded with extraordinary precision, can illuminate the most intimate mysteries of human beginnings.